The Albanese Government expands access to antiviral treatment and offers COVID-19 leave grants to protect older Australians. As we head into the colder months, protecting the elderly from COVID-19 becomes more important than ever. That’s ...
The Australian Government has accepted a recommendation from the ATAGI on the use of the Pfizer Comirnaty Bivalent Original/Omicron BA.1 vaccine as a third and fourth dose in people aged 18 years and older. Australian ...
The Albanese government will spend a further $1.4 billion for COVID-19 response, with the majority of the funding going to aged care providers. The money will be used for continuing a range of response measures, ...
NSW Health has revised the COVID-19 reinfection period from 12 weeks down to four weeks effective from today. People who have previously had COVID-19 should test for COVID-19 after 28 days since their isolation ended ...
All Australians aged over 70 who test positive to COVID will be able to access antiviral medicines on the Pharmaceutical Benefits Scheme (PBS). Access will also be expanded to people aged over 50 with two ...
The Pharmaceutical Society of Australia (PSA) National President Dr Fei Sim is calling on governments to do more to protect the community and prepare for an increasing number of COVID-19 infections and hospitalisations by improving ...
NSW Health is urging people to keep up to date with their COVID-19 vaccinations and practise COVID-safe behaviours this winter as COVID-19 transmission in the community remains high, according to the latest Respiratory Surveillance Report published today. ...
According to a new study led by Monash University, of those admitted to the ICU with COVID-19, after accounting for age and how sick patients were, the third wave of the disease in Australia was associated with ...
Australian COVID-19 cases after the peak of the Omicron wave were at least twice as high as reported to authorities, a blood antibody study shows. The study estimated at least 17 per cent of Australian ...
On 25 March 2022, ATAGI recommended an additional winter booster dose (4th dose for most people) for the highest risk groups: the elderly, residents of aged care or disability care facilities, people with severe immunocompromise, ...
Novavax has been approved as a COVID-19 booster for people aged 18 and above. In a statement released on Tuesday, Novavax announced the Therapeutic Goods Administration had granted provisional registration for the vaccine as a third jab. ...
Experts have warned that the 2022 flu resurgence season will redefine what it means for Australia to be ‘flu ready’ as the National Notifiable Disease Surveillance System reported over 65,775 confirmed cases of influenza in ...
Healthcare Channel – Sharing knowledge and resources for Australia’s health and aged care sector
We always welcome thought leaders ready to mentor the next generation. Be a Healthcare Channel learning partner today!
Healthcare Channel acknowledges the traditional custodians of the lands where we live, learn and work. We pay our respects to Elders past, present and emerging.
Healthcare Channel acknowledges the traditional custodians of the lands where we live, learn and work. We pay our respects to Elders past, present and emerging.
